FindTrial
Sign In

Efficacy of therapeutic emesis with Ikshvaku drug in Psoriasis

A Randomised Control Study to Evaluate The Effectiveness of Vamana Karma with Ikshvaku in Eka-Kushtha - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089193
Enrollment
60
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria Health Condition 2: L503- Dermatographic urticaria

Interventions

None listed

Sponsors

SGT University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients who have scored more than 0 for Asvedanam, Mahavastu & Matsyashakalata lakshana in assessment criteria. 2 Patients having signs and symptoms of Eka-kushtha according to Charaka Samhita. 3 Age group from 20 to 60 yrs. 4 Patient of either sex. 5 Vamanarha patients.

Exclusion criteria

Exclusion criteria: Patients with complications like Cardiac problems, emphysema, carcinoma, etc. will be excluded. Pregnant woman and lactating mothers will be excluded. The patients above 60yrs and below 18yrs will be excluded.

Design outcomes

Primary

MeasureTime frame
Relief in the signs and symptoms of Eka Kushtha like matsyasakalta, aswednam etc.Timepoint: 4 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Rekha Phull

SGT University

rekha.ayurveda@sgtuniversity.org7507373663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026